glucagon-like peptide-1 (GLP-1)
Showing 9976 - 10000 of >10,000
Enterovirus Infections, Influenza Trial in Hangzhou (EV71 vaccine and influenza vaccine, EV71 vaccine, influenza vaccine)
Completed
- Enterovirus Infections
- Influenza
- EV71 vaccine and influenza vaccine
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang provincial center for disease control and prevention
Oct 10, 2022
Malignant Solid Tumor, Metastatic EphA2 Positive Cancer Trial in Heidelberg (DS-8895a 1 mg/kg, DS-8895a 3 mg/kg, DS-8895a 10
Completed
- Malignant Solid Tumor
- Metastatic EphA2 Positive Cancer
- DS-8895a 1 mg/kg
- +2 more
-
Heidelberg, Victoria, AustraliaAustin Health
Oct 3, 2022
Type 1 Diabetes Trial in La Jolla (Acetazolamide)
Not yet recruiting
- Type 1 Diabetes
-
La Jolla, CaliforniaUC San Diego Altman Clinical & Translational Research Institute
Jul 26, 2022
MDD, Treatment Resistant Depression, Smoking Cessation Trial in Baltimore (Dextromethorphan)
Completed
- MDD
- +3 more
-
Baltimore, MarylandJohns Hopkins Department of Psychiatry
Jan 7, 2022
Covid19, SARS-CoV Infection, Coronavirus Infection Trial in Baltimore (Camostat Mesilate, Bicalutamide 150 mg)
Terminated
- Covid19
- +2 more
- Camostat Mesilate
- Bicalutamide 150 mg
-
Baltimore, MarylandJohns Hopkins Hospital
Sep 15, 2021
Diabetes, Type 1 Trial in Warsaw (Phenofibrate, Placebo)
Recruiting
- Diabetes Mellitus, Type 1
- Phenofibrate
- Placebo
-
Warsaw, Mazowieckie, Poland
- +1 more
Jun 8, 2023
Fatigue Trial in Giza (Fatigue protocol (repeated sprint ability), Sham Comparator: Control group)
Completed
- Fatigue
- Fatigue protocol (repeated sprint ability)
- Sham Comparator: Control group
-
Giza, EgyptCairo University
Oct 4, 2023
Breast Cancer Trial in Lisboa (Aerobic Training Group, Resistance Training Group, Control group)
Not yet recruiting
- Breast Cancer
- Aerobic Training Group
- +2 more
-
Lisboa, PortugalFundação Champalimaud
Jul 25, 2022
Advanced Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Boston (AGEN1423,
Not yet recruiting
- Advanced Pancreatic Ductal Adenocarcinoma
- +2 more
- AGEN1423
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Nov 18, 2022
Registration of Sepsis Patients in the Emergency Department
Not yet recruiting
- Sepsis
- no intervention
- (no location specified)
Sep 28, 2023
Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension Trial (BP Threshold for medication initiation)
Not yet recruiting
- Hypertensive Disorder of Pregnancy
- +10 more
- BP Threshold for medication initiation
- (no location specified)
Sep 28, 2023
The Lived Experience of People With Von Willebrand Disease
Not yet recruiting
- Von Willebrand Diseases
- Online Survey
- +2 more
- (no location specified)
Oct 3, 2023
Activity, Motor, Social Isolation Trial in Pittsburgh (Social Incentive, Standard Incentive)
Completed
- Activity, Motor
- Social Isolation
- Social Incentive
- Standard Incentive
-
Pittsburgh, PennsylvaniaCarnegie Mellon University
Jan 5, 2022
Pulpitis - Irreversible Trial in New Delhi (Lidocaine Hydrochloride)
Completed
- Pulpitis - Irreversible
- Lidocaine Hydrochloride
-
New Delhi, IndiaFaculty of Dentistry, Jamia MIliia Islamia
May 4, 2022
Erectile Dysfunction Trial in Thessaloniki (Dornier Aries2 device, Dornier Aries2 device (sham probe))
Completed
- Erectile Dysfunction
- Dornier Aries2 device
- Dornier Aries2 device (sham probe)
-
Thessaloniki, GreeceG.Gennimatas Hospital
May 4, 2022
Atherosclerotic Cardiovascular Disease in Brazilian Population
Recruiting
- Cardiovascular Diseases
- +4 more
- Exposure to genetics (polygenic)
-
Rio Branco, AC, Brazil
- +40 more
Aug 23, 2022
Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston
Active, not recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- +4 more
- Alisertib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Obesity, Diabetes Type 2 Trial in Lancaster (Semaglutide Pen Injector [Ozempic])
Recruiting
- Obesity
- Diabetes Type 2
- Semaglutide Pen Injector [Ozempic]
-
Lancaster, PennsylvaniaAmish Research Clinic
Jul 29, 2022
Alcoholism, Substance-related Disorders, Dual Diagnosis Trial in Charleston (Combined Recovery Program, Stable & Able (S&A))
Not yet recruiting
- Alcoholism
- +2 more
- Combined Recovery Program
- Stable & Able (S&A)
-
Charleston, South CarolinaRalph H. Johnson VA Medical Center, Charleston, SC
Jul 29, 2022
Tinea Cruris, Tinea Pedis Trial in United States (UHE-103 Cream, Naftin (naftifine HCl) Cream)
Recruiting
- Tinea Cruris
- Tinea Pedis
- UHE-103 Cream
- Naftin (naftifine hydrochloride) Cream
-
San Diego, California
- +4 more
May 2, 2022
Aortic Valve-sparing Root Replacement, According to Inclusion
Recruiting
- Aortic Root Aneurysm
- Aortic Regurgitation
- No intervention
-
Nantes, FranceNantes University Hospital
Aug 23, 2022
Special Drug Use-results Surveillance of Tabrecta Tablets
Recruiting
- Non-small Cell Lung Cancer
- Tabrecta tablets
-
Nagoya, Aichi, Japan
- +44 more
Aug 1, 2022